HAMPTON, N.J., July 12, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Celldex or the Company) (Nasdaq: CLDX) today announced that it is proposing to offer and sell, subject to market conditions, $175 million of shares of its common stock in an underwritten…
Morgan Stanley tweaks Micron stock price target as pressure builds
February 12, 2026
